Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
letter
. 1996;22(1):87. doi: 10.1007/BF01728337

Exogenous surfactant therapy for acute respiratory distress in infancy

M Moreno 1,, J López-Herce 1, C Merello 1, A Alcaraz 1, A Carrillo 1
PMCID: PMC7095323  PMID: 8857444

The content is available as a PDF (116.2 KB).

References

  • 1.Lugo RA, Nahata MC. Pathogenesis and treatment of bronchiolitis. Clin Pharm. 1993;12:95–116. [PubMed] [Google Scholar]
  • 2.Bachmann DCG, Pfenninger J. Respiratory syncitial virus triggered adult respiratory distress syndrome in infants: a report of two cases. Intensive Care Med. 1994;20:61–63. doi: 10.1007/BF02425060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Weinberger SE. Recent advances in pulmonary medicine. N Engl J Med. 1993;328:1462–1470. doi: 10.1056/NEJM199305203282007. [DOI] [PubMed] [Google Scholar]
  • 4.Mikawa K, Maekawa N, Nishina K, Tanaka O, Yaku H, Obara H. Improvement of gas exchange following endobronchial instillation of an exogenous surfactant in an infant with respiratory failure by postoperative pulmonary haemorrhage. Intensive Care Med. 1994;20:59–60. doi: 10.1007/BF02425059. [DOI] [PubMed] [Google Scholar]
  • 5.Aldamiz-Echevarría L, Rodriguez J, Arana J, Emaparanza JI, Izquierdo MA, Landa J. Presentación de un lactante afecto de distrés respiratorio tipo adulto y tratado con surfactante pulmonar. An Esp Pediatr. 1994;40:311–312. [Google Scholar]

Articles from Intensive Care Medicine are provided here courtesy of Nature Publishing Group

RESOURCES